- call +1-201-465-4211
- email sales@mrinsights.biz
Percutaneous coronary intervention (PCI) is a non-surgical procedure in which a catheter or a stent is used to open narrowed blood vessels which are blocked by deposition of plaque. It is used to improve blood flow and decrease heart-related chest pain improving the patients condition.
Scope of the Report:
This report studies the Complex Percutaneous Coronary Intervention market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Complex Percutaneous Coronary Intervention market by product type and applications/end industries.
The global Complex Percutaneous Coronary Intervention market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Complex Percutaneous Coronary Intervention.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Medtronic
Boston Scientific Corporation
B. Braun Melsungen
Biosensors International Group
Biotronik
Terumo Corporation
Johnson & Johnson
Getinge
St. Jude Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drug-Eluting Stents (DES)
Bare Metal Stents
Bioresorbable Stents
Market Segment by Applications, can be divided into
Percutaneous Coronary Intervention (PCI)
Transcatheter Aortic Valve Implantation (TAVI/TAVR)
Trans-Mitral Valve Implantation (TMVR)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Complex Percutaneous Coronary Intervention Market Overview
1.1 Product Overview and Scope of Complex Percutaneous Coronary Intervention
1.2 Classification of Complex Percutaneous Coronary Intervention by Types
1.2.1 Global Complex Percutaneous Coronary Intervention Revenue Comparison by Types (2017-2023)
1.2.2 Global Complex Percutaneous Coronary Intervention Revenue Market Share by Types in 2017
1.2.3 Drug-Eluting Stents (DES)
1.2.4 Bare Metal Stents
1.2.5 Bioresorbable Stents
1.3 Global Complex Percutaneous Coronary Intervention Market by Application
1.3.1 Global Complex Percutaneous Coronary Intervention Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Percutaneous Coronary Intervention (PCI)
1.3.3 Transcatheter Aortic Valve Implantation (TAVI/TAVR)
1.3.4 Trans-Mitral Valve Implantation (TMVR)
1.4 Global Complex Percutaneous Coronary Intervention Market by Regions
1.4.1 Global Complex Percutaneous Coronary Intervention Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Complex Percutaneous Coronary Intervention Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Complex Percutaneous Coronary Intervention Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Complex Percutaneous Coronary Intervention Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Complex Percutaneous Coronary Intervention Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Complex Percutaneous Coronary Intervention Status and Prospect (2013-2023)
1.5 Global Market Size of Complex Percutaneous Coronary Intervention (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Complex Percutaneous Coronary Intervention Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic
2.2.1 Business Overview
2.2.2 Complex Percutaneous Coronary Intervention Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boston Scientific Corporation
2.3.1 Business Overview
2.3.2 Complex Percutaneous Coronary Intervention Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boston Scientific Corporation Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.4 B. Braun Melsungen
2.4.1 Business Overview
2.4.2 Complex Percutaneous Coronary Intervention Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 B. Braun Melsungen Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biosensors International Group
2.5.1 Business Overview
2.5.2 Complex Percutaneous Coronary Intervention Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biosensors International Group Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biotronik
2.6.1 Business Overview
2.6.2 Complex Percutaneous Coronary Intervention Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biotronik Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.7 Terumo Corporation
2.7.1 Business Overview
2.7.2 Complex Percutaneous Coronary Intervention Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Terumo Corporation Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Complex Percutaneous Coronary Intervention Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.9 Getinge
2.9.1 Business Overview
2.9.2 Complex Percutaneous Coronary Intervention Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Getinge Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
2.10 St. Jude Medical
2.10.1 Business Overview
2.10.2 Complex Percutaneous Coronary Intervention Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 St. Jude Medical Complex Percutaneous Coronary Intervention Revenue, Gross Margin and Market Share (2016-2017)
3 Global Complex Percutaneous Coronary Intervention Market Competition, by Players
3.1 Global Complex Percutaneous Coronary Intervention Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Complex Percutaneous Coronary Intervention Players Market Share
3.2.2 Top 10 Complex Percutaneous Coronary Intervention Players Market Share
3.3 Market Competition Trend
4 Global Complex Percutaneous Coronary Intervention Market Size by Regions
4.1 Global Complex Percutaneous Coronary Intervention Revenue and Market Share by Regions
4.2 North America Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
4.3 Europe Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
4.5 South America Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
5 North America Complex Percutaneous Coronary Intervention Revenue by Countries
5.1 North America Complex Percutaneous Coronary Intervention Revenue by Countries (2013-2018)
5.2 USA Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
5.3 Canada Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
5.4 Mexico Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
6 Europe Complex Percutaneous Coronary Intervention Revenue by Countries
6.1 Europe Complex Percutaneous Coronary Intervention Revenue by Countries (2013-2018)
6.2 Germany Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
6.3 UK Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
6.4 France Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
6.5 Russia Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
6.6 Italy Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Complex Percutaneous Coronary Intervention Revenue by Countries
7.1 Asia-Pacific Complex Percutaneous Coronary Intervention Revenue by Countries (2013-2018)
7.2 China Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
7.3 Japan Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
7.4 Korea Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
7.5 India Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
8 South America Complex Percutaneous Coronary Intervention Revenue by Countries
8.1 South America Complex Percutaneous Coronary Intervention Revenue by Countries (2013-2018)
8.2 Brazil Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
8.3 Argentina Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
8.4 Colombia Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Complex Percutaneous Coronary Intervention by Countries
9.1 Middle East and Africa Complex Percutaneous Coronary Intervention Revenue by Countries (2013-2018)
9.2 Saudi Arabia Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
9.3 UAE Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
9.4 Egypt Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
9.5 Nigeria Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
9.6 South Africa Complex Percutaneous Coronary Intervention Revenue and Growth Rate (2013-2018)
10 Global Complex Percutaneous Coronary Intervention Market Segment by Type
10.1 Global Complex Percutaneous Coronary Intervention Revenue and Market Share by Type (2013-2018)
10.2 Global Complex Percutaneous Coronary Intervention Market Forecast by Type (2018-2023)
10.3 Drug-Eluting Stents (DES) Revenue Growth Rate (2013-2023)
10.4 Bare Metal Stents Revenue Growth Rate (2013-2023)
10.5 Bioresorbable Stents Revenue Growth Rate (2013-2023)
11 Global Complex Percutaneous Coronary Intervention Market Segment by Application
11.1 Global Complex Percutaneous Coronary Intervention Revenue Market Share by Application (2013-2018)
11.2 Complex Percutaneous Coronary Intervention Market Forecast by Application (2018-2023)
11.3 Percutaneous Coronary Intervention (PCI) Revenue Growth (2013-2018)
11.4 Transcatheter Aortic Valve Implantation (TAVI/TAVR) Revenue Growth (2013-2018)
11.5 Trans-Mitral Valve Implantation (TMVR) Revenue Growth (2013-2018)
12 Global Complex Percutaneous Coronary Intervention Market Size Forecast (2018-2023)
12.1 Global Complex Percutaneous Coronary Intervention Market Size Forecast (2018-2023)
12.2 Global Complex Percutaneous Coronary Intervention Market Forecast by Regions (2018-2023)
12.3 North America Complex Percutaneous Coronary Intervention Revenue Market Forecast (2018-2023)
12.4 Europe Complex Percutaneous Coronary Intervention Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Complex Percutaneous Coronary Intervention Revenue Market Forecast (2018-2023)
12.6 South America Complex Percutaneous Coronary Intervention Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Complex Percutaneous Coronary Intervention Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Complex Percutaneous Coronary Intervention Picture
Table Product Specifications of Complex Percutaneous Coronary Intervention
Table Global Complex Percutaneous Coron
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
